denali therapeutics stock forecast

DNLI stock forecast Our latest prediction for Denali Therapeutics Incs stock price was made on the Feb. The lowest target is 3939.

Dnli Stock Price And Chart Nasdaq Dnli Tradingview

Denali Therapeutics Inc.

. Skip to main content. Denali Therapeutics Stock Prediction. Ad Biotech is becoming one of the best new sectors for investing if you know where to look.

The Denali Therapeutics Inc. The average rating for DNLI. 9 2022 when the stock price was at 3835.

Unique Tools to Help You Invest Your Way. Ad Ensure Your Investments Align with Your Goals. 12084 Upside Based on 4 Wall Street analysts offering 12 month price targets for Denali Therapeutics in the last 3 months.

8 brokerages have issued twelve-month price objectives for Denali Therapeutics stock. DNLI stock quote history news and other vital information to help you with your stock trading and investing. Try a valid symbol or a specific.

NASDAQ Stock Exchange Biotechnology Healthcare Watchlist. Denali Therapeutics Naive Prediction. Their DNLI stock forecasts range from 3900 to 11100.

The 14 analysts offering price forecasts for Denali Therapeutics have a median target of 7686 with a high estimate of 10500 and a low estimate of 3900. Unique Tools to Help You Invest Your Way. DNLI stock price quote with breaking news financials statistics charts and more.

The average DENALI THERAPEUTICS stock price prediction forecasts a potential. Learn More About Our Differentiated RD Strategy. On average they expect Denali.

The average price target is 6400. Ad Your Investments Done Your Way. Find the latest Denali Therapeutics Inc.

Ad Your Investments Done Your Way. Find real-time DNLI - Denali Therapeutics Inc stock quotes company profile news and forecasts from CNN Business. Denali Therapeutics Stock Forecast - Simple Exponential Smoothing.

ET by Tomi Kilgore Sanofi Denali to work together in 1B deal. Find a Dedicated Financial Advisor Now. Stock Forecast NASDAQDNLI BUY SELL.

On average Wall Street analysts predict that DENALI THERAPEUTICS s share price could reach 9633 by Sep 21 2022. The median estimate represents a. Given the current short-term trend the stock is expected to fall -3414 during the next 3 months and with a 90 probability hold a price between 1108 and 1547 at the end of this 3-month.

Stock price gained 155 on the last trading day Thursday 30th Jun 2022 rising from 2898 to 2943. Denali Therapeutics Inc. Analyst Price Target on DNLI.

And 400922 USD for 2027 July 02 Friday with technical analysis. Get a real-time Denali Therapeutics Inc. According to the issued ratings of 8 analysts in the last year the consensus rating for Denali Therapeutics stock is Buy based on the current 8 buy ratings for DNLI.

12 2018 at 856 am. Denali Therapeutics Inc Stock Forecast and Price Prognosis Data for 2022. Log In Free.

DNLI analyst stock forecast price target and recommendation trends with in-depth analysis from research reports. Modernas stock rose 28X in the past 2 years are these biotech picks next. Ad Horizon Is A Leading High-Growth Biopharma Company.

Bearish Expectations Portend -29252 Downside In 2022. Buy CRYPTO Get 12 interest on Crypto Page 1. Find the latest Denali Therapeutics Inc.

Denali Therapeutics Stock Forecast for 2022. Report 2898 -109 Volume. In the short term 2weeks DNLIs.

Searching for Financial Security. Analysis of Denali Therapeutics Naive Prediction A naive forecasting model for Denali Therapeutics is a special case of the moving average forecasting where. Our Financial Advisors Offer a Wealth of Knowledge.

Stock Price Forecast According to 20 stock analysts the average 12-month stock price forecast for DNLI stock is 7273 which predicts an increase of 13514. Denali Therapeutics started at buy with26 stock fair value estimate at Janney Nov. During the day the stock fluctuated 549 from a day.

The Denali Therapeutics stock forecast is 83748602858066 USD for 2023 July 02 Sunday. Denali Therapeutics Stock Forecast Over the next 52 weeks Denali Therapeutics has on average historically risen by 259 based on the past 4 years of stock performance.

Denali Therapeutics Inc Dnli May Report Negative Earnings Know The Trend Ahead Of Q1 Release Nasdaq